Cargando…

Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy

OBJECTIVE: The objective of the current study was to compare the responses to different ex vivo immunogenic challenges between immune cells derived from metabolically healthy subjects with obesity and subjects with obesity and type 2 diabetes. RESEARCH DESIGN AND METHODS: We recruited 10 metabolical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richard, Caroline, Wadowski, Michael, Goruk, Susan, Cameron, Lisa, Sharma, Arya M, Field, Catherine J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Open Diabetes Research & Care 2017
Materias:	Immunology and Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530252/ https://www.ncbi.nlm.nih.gov/pubmed/28761653 http://dx.doi.org/10.1136/bmjdrc-2016-000379

Ejemplares similares

T-Cell Costimulation Protects Obesity-Induced Adipose Inflammation and Insulin Resistance
por: Zhong, Jixin, et al.
Publicado: (2014)

Obesity and listing for renal transplantation: weighing the evidence for a growing problem
por: Hossain, Mohammed, et al.
Publicado: (2017)

Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes
por: Kwon, Bum Chul, et al.
Publicado: (2022)

Should donors who have used marijuana be considered candidates for living kidney donation?
por: Ruckle, David, et al.
Publicado: (2018)

The Radioprotective 105/MD-1 Complex Contributes to Diet-Induced Obesity and Adipose Tissue Inflammation
por: Watanabe, Yasuharu, et al.
Publicado: (2012)

TACI-Deficient Macrophages Protect Mice Against Metaflammation and Obesity-Induced Dysregulation of Glucose Homeostasis
por: Liu, Lunhua, et al.
Publicado: (2018)

Impact of Diabetes Susceptibility Loci on Progression From Pre-Diabetes to Diabetes in At-Risk Individuals of the Diabetes Prevention Trial–Type 1 (DPT-1)
por: Butty, Vincent, et al.
Publicado: (2008)

ALEMTUZUMAB FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION
por: Girgis, Reda, et al.
Publicado: (2020)

Cardiovascular effects of metabolic syndrome after transplantation: convergence of obesity and transplant-related factors
por: Sgambat, Kristen, et al.
Publicado: (2018)

Glycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes: A Twin and Population Study
por: Beyan, Huriya, et al.
Publicado: (2012)

Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect
por: Stone, Virginia M., et al.
Publicado: (2021)

Obesity Increases Gene Expression of Markers Associated With Immunosenescence in Obese Middle-Aged Individuals
por: Brunelli, Diego T., et al.
Publicado: (2022)

Natural Killer Cells From Children With Type 1 Diabetes Have Defects in NKG2D-Dependent Function and Signaling
por: Qin, Huilian, et al.
Publicado: (2011)

Individuals with Metabolically Healthy Overweight/Obesity Have Higher Fat Utilization than Metabolically Unhealthy Individuals
por: Pujia, Arturo, et al.
Publicado: (2016)

Outcomes after heart transplantation in patients who have undergone a bridge-to-bridge strategy
por: Zhou, Alice L., et al.
Publicado: (2022)

Liver Transplantation With Grafts From Super Obese Donors
por: Vargas, Paola A., et al.
Publicado: (2021)

Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity
por: Kim, Nam Hoon, et al.
Publicado: (2022)

Phenotypic and Functional Characterization of Double Negative B Cells in the Blood of Individuals With Obesity
por: Frasca, Daniela, et al.
Publicado: (2021)

Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation
por: Ren, Xiying, et al.
Publicado: (2021)

The metabolome profiling of obese and non-obese individuals: Metabolically healthy obese and unhealthy non-obese paradox
por: Chashmniam, Saeed, et al.
Publicado: (2020)

Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects
por: Abramowicz, Daniel, et al.
Publicado: (2008)

Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain
por: Soma, Daiki, et al.
Publicado: (2022)

The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease
por: Pang, Yifan, et al.
Publicado: (2022)

IRAK-M Deficiency Promotes the Development of Type 1 Diabetes in NOD Mice
por: Tan, Qiyuan, et al.
Publicado: (2014)

Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals
por: Ahmad, Aftab, et al.
Publicado: (2019)

Expression and Regulation of Chemokines in Murine and Human Type 1 Diabetes
por: Sarkar, Suparna A., et al.
Publicado: (2012)

B-Lymphocytes Expressing an Ig Specificity Recognizing the Pancreatic β-Cell Autoantigen Peripherin Are Potent Contributors to Type 1 Diabetes Development in NOD Mice
por: Leeth, Caroline M., et al.
Publicado: (2016)

Population-based Trends in Obesity and Kidney Transplantation Among Patients With End-stage Kidney Disease
por: Wakam, Glenn K., et al.
Publicado: (2021)

Deletion of the G6pc2 Gene Encoding the Islet-Specific Glucose-6-Phosphatase Catalytic Subunit–Related Protein Does Not Affect the Progression or Incidence of Type 1 Diabetes in NOD/ShiLtJ Mice
por: Oeser, James K., et al.
Publicado: (2011)

Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8(+) T Cells
por: Pearson, James A., et al.
Publicado: (2016)

Assessment of β-Cell Mass and α- and β-Cell Survival and Function by Arginine Stimulation in Human Autologous Islet Recipients
por: Robertson, R. Paul, et al.
Publicado: (2015)

Interleukin-10(+) Regulatory B Cells Arise Within Antigen-Experienced CD40(+) B Cells to Maintain Tolerance to Islet Autoantigens
por: Kleffel, Sonja, et al.
Publicado: (2015)

Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes
por: Acevedo-Calado, Maria J., et al.
Publicado: (2019)

Tolerogenic Dendritic Cells Shape a Transmissible Gut Microbiota That Protects From Metabolic Diseases
por: Lécuyer, Emelyne, et al.
Publicado: (2021)

Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
por: Arif, Sefina, et al.
Publicado: (2014)

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA(1c), and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
por: Haller, Michael J., et al.
Publicado: (2019)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN RENAL TRANSPLANT PATIENTS WITH COVID-19
por: MAHONEY, IAN, et al.
Publicado: (2022)

Individuals with obesity who survive SARS‐CoV‐2 infection have preserved antigen‐specific T cell frequencies
por: Wrigley Kelly, Neil E., et al.
Publicado: (2022)

Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity
por: Trim, William, et al.
Publicado: (2018)

Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation
por: Pessentheiner, Ariane R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2kg08d38l5jlchadr6nec597q6